Robin Murray

161.2k total citations · 31 hit papers
1.6k papers, 89.9k citations indexed

About

Robin Murray is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Robin Murray has authored 1.6k papers receiving a total of 89.9k indexed citations (citations by other indexed papers that have themselves been cited), including 783 papers in Psychiatry and Mental health, 309 papers in Clinical Psychology and 292 papers in Cognitive Neuroscience. Recurrent topics in Robin Murray's work include Schizophrenia research and treatment (655 papers), Bipolar Disorder and Treatment (222 papers) and Functional Brain Connectivity Studies (184 papers). Robin Murray is often cited by papers focused on Schizophrenia research and treatment (655 papers), Bipolar Disorder and Treatment (222 papers) and Functional Brain Connectivity Studies (184 papers). Robin Murray collaborates with scholars based in United Kingdom, United States and Ireland. Robin Murray's co-authors include Peter B. Jones, Philip McGuire, Pak C. Sham, Mary Cannon, Shôn Lewis, Paola Dazzan, Marta Di Forti, Jim van Os, Oliver Howes and Craig Morgan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Robin Murray

1.5k papers receiving 85.9k citations

Hit Papers

A Randomized, Placebo-Controlled Trial of Z... 1978 2026 1994 2010 2002 2000 1995 2002 2000 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma
    2002 1.2k citations Robin Murray et al. profile →
  2. Meta-Analysis of Regional Brain Volumes in Schizophrenia
    2000 1.2k citations Anthony S. David, Robin Murray et al. American Journal of Psychiatry profile →
  3. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
    1995 1.2k citations Robin Murray et al. profile →
  4. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
    2002 956 citations Robin Murray et al. profile →
  5. Children's Self-Reported Psychotic Symptoms and Adult Schizophreniform Disorder
    2000 876 citations Robin Murray et al. profile →
  6. Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction
    2005 873 citations Robin Murray et al. Biological Psychiatry profile →
  7. Obstetric Complications and Schizophrenia: Historical and Meta-Analytic Review
    2002 784 citations Peter B. Jones, Robin Murray et al. American Journal of Psychiatry profile →
  8. Schizophrenia
    2015 775 citations Robin Murray et al. profile →
  9. Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia
    2006 755 citations Peter B. Jones, Robin Murray et al. profile →
  10. Is schizophrenia a neurodevelopmental disorder?
    1987 670 citations Robin Murray, Shôn Lewis profile →
  11. Causal association between cannabis and psychosis: examination of the evidence
    2004 641 citations Robin Murray et al. The British Journal of Psychiatry profile →
  12. Schizophrenia: an integrated sociodevelopmental-cognitive model
    2013 599 citations Oliver Howes, Robin Murray The Lancet profile →
  13. Evidence for Early-Childhood, Pan-Developmental Impairment Specific to Schizophreniform Disorder
    2002 583 citations Robin Murray et al. profile →
  14. Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
    2009 570 citations Oliver Howes, Robin Murray et al. profile →
  15. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.
    1999 569 citations Shôn Lewis, Pak C. Sham et al. profile →
  16. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders.
    1996 558 citations David Collier, Robin Murray et al. profile →
  17. Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
    2009 541 citations Paul D. Morrison, Mitul A. Mehta et al. profile →
  18. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
    2016 535 citations Marta Di Forti, Robin Murray et al. Schizophrenia Bulletin profile →
  19. Atlasing location, asymmetry and inter-subject variability of white matter tracts in the human brain with MR diffusion tractography
    2010 508 citations Matthew Allin, Muriel Walshe et al. profile →
  20. Symmetries in human brain language pathways correlate with verbal recall
    2007 500 citations Marco Catani, Matthew Allin et al. Proceedings of the National Academy of Sciences profile →
  21. Animal models in psychiatry and neurology
    1978 499 citations Robin Murray profile →
  22. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia
    2016 400 citations Oliver Howes, Robert A. McCutcheon et al. Biological Psychiatry profile →
  23. Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study
    2010 396 citations Robin Murray et al. American Journal of Psychiatry profile →
  24. What causes psychosis? An umbrella review of risk and protective factors
    2018 383 citations Craig Morgan, Philip McGuire et al. profile →
  25. Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-Analyses
    2012 381 citations James B. Kirkbride, Tim Croudace et al. profile →
  26. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
    2012 361 citations Amir Englund, Paul D. Morrison et al. Journal of Psychopharmacology profile →
  27. Preterm Birth and Psychiatric Disorders in Young Adult Life
    2012 343 citations Robin Murray, James H. MacCabe et al. profile →
  28. Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies
    2017 240 citations John Lally, Brendon Stubbs et al. The British Journal of Psychiatry profile →
  29. The clinical characterization of the patient with primary psychosis aimed at personalization of management
    2021 166 citations Mario Maj, Peter B. Jones et al. profile →
  30. Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas
    2021 153 citations Robin Murray, Peter B. Jones et al. profile →
  31. The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
    2023 67 citations Robin Murray et al. Schizophrenia Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Murray United Kingdom 154 42.1k 20.7k 19.3k 9.7k 9.6k 1.6k 89.9k
Nancy C. Andreasen United States 120 29.2k 0.7× 22.3k 1.1× 10.3k 0.5× 5.7k 0.6× 3.0k 0.3× 515 56.9k
Jeffrey A. Lieberman United States 121 34.0k 0.8× 9.1k 0.4× 8.8k 0.5× 8.6k 0.9× 4.6k 0.5× 602 54.1k
Daniel R. Weinberger United States 141 25.5k 0.6× 33.9k 1.6× 8.8k 0.5× 22.7k 2.3× 3.3k 0.3× 719 83.1k
Philip McGuire United Kingdom 123 25.4k 0.6× 25.9k 1.3× 9.3k 0.5× 6.9k 0.7× 6.7k 0.7× 892 56.3k
Jim van Os Netherlands 123 36.4k 0.9× 10.8k 0.5× 23.6k 1.2× 3.7k 0.4× 5.4k 0.6× 1.1k 68.0k
Ming T. Tsuang United States 116 23.4k 0.6× 12.5k 0.6× 13.3k 0.7× 4.4k 0.5× 2.1k 0.2× 841 49.1k
Stephen V. Faraone United States 154 72.9k 1.7× 39.9k 1.9× 31.0k 1.6× 8.1k 0.8× 2.4k 0.3× 1.3k 101.5k
John M. Kane United States 118 36.1k 0.9× 6.0k 0.3× 9.8k 0.5× 4.9k 0.5× 5.8k 0.6× 928 52.6k
René S. Kahn Netherlands 108 16.3k 0.4× 19.3k 0.9× 5.5k 0.3× 5.1k 0.5× 3.5k 0.4× 734 45.5k
Peter B. Jones United Kingdom 114 22.4k 0.5× 6.8k 0.3× 16.1k 0.8× 2.6k 0.3× 3.4k 0.4× 857 50.2k

Countries citing papers authored by Robin Murray

Since Specialization
Citations

This map shows the geographic impact of Robin Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Murray more than expected).

Fields of papers citing papers by Robin Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Murray. The network helps show where Robin Murray may publish in the future.

Co-authorship network of co-authors of Robin Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Murray. A scholar is included among the top collaborators of Robin Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Murray. Robin Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osugo, Martin, Matthew B. Wall, Pierluigi Selvaggi, et al.. (2025). Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour. Nature Communications. 16(1). 1852–1852. 6 indexed citations
2.
3.
Murray, Robin, Alice Egerton, Anthony A. Grace, et al.. (2025). Why Is Clozapine Uniquely Effective in Treatment-Resistant Schizophrenia? A Review and Proposal. Biological Psychiatry. 99(7). 517–526.
4.
Hübel, Christopher, Molly R. Davies, Jonathan R. I. Coleman, et al.. (2023). Genetic examination of the Mood Disorder Questionnaire and its relationship with bipolar disorder. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 192(7-8). 147–160. 7 indexed citations
5.
Gaughran, Fiona, Daniel Ståhl, Anita Patel, et al.. (2020). A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT RCT. SHILAP Revista de lepidopterología. 8(1). 1–124. 6 indexed citations
6.
Vieira, Sandra, Qiyong Gong, Walter Hugo Lopez Pinaya, et al.. (2018). Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence. Schizophrenia Bulletin. 46(1). 17–26. 65 indexed citations
7.
Heslin, Margaret, Julia Lappin, Kim Donoghue, et al.. (2016). Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients. Schizophrenia Research. 176(2-3). 417–422. 24 indexed citations
8.
Heslin, Margaret, Roopal Desai, Julia Lappin, et al.. (2015). Biological and psychosocial risk factors for psychotic major depression. Social Psychiatry and Psychiatric Epidemiology. 51(2). 233–245. 19 indexed citations
9.
Kirkbride, James B., Dan Jackson, Jesús Pérez, et al.. (2013). A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data. BMJ Open. 3(2). e001998–e001998. 35 indexed citations
10.
Frangou, Sophia, P Boyer, J Guelfi, et al.. (2012). EPA volume 27 issue 2 Cover and Front matter. European Psychiatry. 27(2). f1–f2. 2 indexed citations
11.
Englund, Amir, Paul D. Morrison, Judith Nottage, et al.. (2012). Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology. 27(1). 19–27. 361 indexed citations breakdown →
12.
Mondelli, Valeria, Annamaria Cattaneo, Martino Belvederi Murri, et al.. (2011). Stress and inflammation reduce BDNF expression in first-episode psychosis: a pathway to smaller hippocampal volume. Proceedings of The Physiological Society. 4 indexed citations
13.
Howes, Oliver, Subrata K. Bose, Federico Turkheimer, et al.. (2011). Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study. American Journal of Psychiatry. 168(12). 1311–1317. 274 indexed citations
14.
Fu, Cynthia H.Y., Steven Williams, Anthony J. Cleare, et al.. (2008). Neural Responses to Sad Facial Expressions in Major Depression Following Cognitive Behavioral Therapy. Biological Psychiatry. 64(6). 505–512. 246 indexed citations
15.
Catani, Marco, Matthew Allin, Masud Husain, et al.. (2007). Symmetries in human brain language pathways correlate with verbal recall. Proceedings of the National Academy of Sciences. 104(43). 17163–17168. 500 indexed citations breakdown →
16.
Allin, Matthew, Marion Cuddy, John Wyatt, et al.. (2006). Personality in Young Adults Who Are Born Preterm. PEDIATRICS. 117(2). 309–316. 102 indexed citations
17.
Fearon, Paul, Pak C. Sham, Peter B. Jones, et al.. (2002). The relationship between predisposing factors, premorbid function and symptom dimensions in psychosis: an integrated approach. European Psychiatry. 17(6). 311–320. 20 indexed citations
18.
Meira‐Lima, Ivanor, David Collier, Robin Murray, et al.. (1998). Inheritance of a CAG/CTG repeat in the HKCA3 gene in families with bipolar affective disorder. American Journal of Medical Genetics Part A. 81(6). 508–509. 1 indexed citations
19.
Persaud, Rajendra, et al.. (1994). Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls. Schizophrenia Research. 11(3). 139–140. 1 indexed citations
20.
O’Callaghan, E., Pak C. Sham, N Takei, Robin Murray, & Gyles Glover. (1991). Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. The Lancet. 337(8752). 1248–1250. 308 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy C. Andreasen Breakdown of academic impact, for papers by Jeffrey A. Lieberman Breakdown of academic impact, for papers by Daniel R. Weinberger Breakdown of academic impact, for papers by Philip McGuire Breakdown of academic impact, for papers by Jim van Os Breakdown of academic impact, for papers by Ming T. Tsuang Breakdown of academic impact, for papers by Stephen V. Faraone Breakdown of academic impact, for papers by John M. Kane Breakdown of academic impact, for papers by René S. Kahn Breakdown of academic impact, for papers by Peter B. Jones
Rankless by CCL
2026